Results 21 to 30 of about 77 (66)

Vaccination Accelerates Liver-Intrinsic Expression of Megakaryocyte-Related Genes in Response to Blood-Stage Malaria

open access: yesVaccines, 2022
Erythropoiesis and megakaryo-/thrombopoiesis occur in the bone marrow proceeding from common, even bipotent, progenitor cells. Recently, we have shown that protective vaccination accelerates extramedullary hepatic erythroblastosis in response to blood ...
Frank Wunderlich   +3 more
doaj   +1 more source

Human Epidermal Growth Factor Receptor-3 mRNA Expression as a Prognostic Marker for Invasive Duct Carcinoma not Otherwise Specified [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Introduction: Breast cancer is the most common cancer in women and the Erythroblastosis Oncogene B(ErbB) receptor family holds crucial role in its pathogenesis.
Ghada Ezat Hammoda   +3 more
doaj   +1 more source

Large-scale analysis by SAGE reveals new mechanisms of v-erbA oncogene action

open access: yesBMC Genomics, 2007
Background: The v-erbA oncogene, carried by the Avian Erythroblastosis Virus, derives from the c-erbAα proto-oncogene that encodes the nuclear receptor for triiodothyronine (T3R).
Faure Claudine   +8 more
doaj   +1 more source

Prevalence and clinical application of TMPRSS2-ERG fusion in Asian prostate cancer patients: a large-sample study in Chinese people and a systematic review

open access: yesAsian Journal of Andrology, 2020
Fusion between the transmembrane protease serine 2 and v-ets erythroblastosis virus E26 oncogene homolog (TMPRSS2-ERG fusion) is a common genetic alteration in prostate cancer among Western populations and has been suggested as playing a role in ...
De-Pei Kong   +8 more
doaj   +1 more source

Transcription Factor ETS-1 and Reactive Oxygen Species: Role in Vascular and Renal Injury

open access: yesAntioxidants, 2018
The E26 avian erythroblastosis virus transcription factor-1 (ETS-1) is a member of the ETS family and regulates the expression of a variety of genes including growth factors, chemokines and adhesion molecules. Although ETS-1 was discovered as an oncogene,
Yan-Ting Shiu, Edgar A. Jaimes
doaj   +1 more source

A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model. [PDF]

open access: yesPLoS ONE, 2014
The erythroblastosis virus E26 transforming sequences (ETS) family of transcription factors consists of a highly conserved group of genes that play important roles in cellular proliferation, differentiation, migration and invasion.
Said Rahim   +13 more
doaj   +1 more source

Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation

open access: yesRetrovirology, 2008
The Friend virus SFFV (Spleen Focus Forming Virus) provokes an acute erythroblastosis in susceptible strains of mice that progresses to overt erythroleukemia by a multi-step process.
Moreau-Gachelin Françoise
doaj   +1 more source

Vertical transmission of avian leukosis virus subgroup J (ALV-J) from hens infected through artificial insemination with ALV-J infected semen

open access: yesBMC Veterinary Research, 2017
Background Avian leukosis virus (ALV) is one of the main causes of tumour development within the poultry industry in China. The subgroup J avian leukosis viruses (ALV-J), which induce erythroblastosis and myelocytomatosis, have the greatest pathogenicity
Yang Li   +6 more
doaj   +1 more source

Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review

open access: yesBMC Pregnancy and Childbirth
Background Hemolytic disease of the fetus and newborn (HDFN) is a condition due to maternal blood group antibodies targeting antigens in fetal red blood cells, with significant prenatal/perinatal morbidity and mortality.
Mário Dias Corrêa Júnior   +5 more
doaj   +1 more source

Overlapping Toxicities of Pembrolizumab and Lenvatinib: A Case of Capillary Leak Syndrome with Severe Erythroblastosis

open access: yesCurrent Oncology
Combined immune checkpoint inhibition (ICI) and multitargeted tyrosine kinase inhibition (TKI) improve outcomes in advanced melanoma, especially in heavily pretreated patients, but introduce complex, overlapping toxicities.
Aikaterini Gkoufa   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy